Revelation Biosciences, Inc. (REVB)
NASDAQ: REVB · Real-Time Price · USD
0.413
+0.013 (3.20%)
At close: Jan 21, 2025, 4:00 PM
0.422
+0.009 (2.18%)
After-hours: Jan 21, 2025, 7:55 PM EST
Revelation Biosciences Market Cap
Revelation Biosciences has a market cap or net worth of $1.77 million as of January 21, 2025. Its market cap has decreased by -41.96% in one year.
Market Cap
1.77M
Enterprise Value
-4.85M
1-Year Change
-41.96%
Ranking
Category
Stock Price
$0.41
Market Cap Chart
Since November 17, 2020, Revelation Biosciences's market cap has decreased from $90.67M to $1.77M, a decrease of -98.05%. That is a compound annual growth rate of -61.08%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jan 17, 2025 | 1.72M | -13.21% |
Dec 31, 2024 | 1.98M | -37.24% |
Dec 29, 2023 | 3.15M | -29.53% |
Dec 30, 2022 | 4.47M | -93.31% |
Dec 31, 2021 | 66.84M | -28.41% |
Dec 31, 2020 | 93.37M | 2.97% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 653.46B |
UnitedHealth Group | 469.12B |
Johnson & Johnson | 353.99B |
Novo Nordisk | 352.70B |
AbbVie | 303.17B |
Merck & Co. | 247.70B |
Thermo Fisher Scientific | 214.07B |
Intuitive Surgical | 211.09B |